12:16 AM EDT, 08/12/2026 (MT Newswires) -- German specialty pharma group Medios (ILM1.F) said Tuesday it agreed to buy a 74% stake in active pharmaceutical ingredients supplier Caesar & Loretz. The transaction, subject to antitrust approval, is expected to broaden the companies' respective offerings and boost value for the pharmacies they serve. Caesar & Loretz will continue to operate independently following the transaction. Medios said the acquisition is not expected to have a material impact on its 2026 outlook.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.